Lars Eichhorn1, Marcus Thudium, Björn Jüttner. 1. Department of Anaesthesiology and Intensive Care University Hospital Bonn (UKB), Bonn Clinic for Anesthesiology and Intensive Care Medicine, Hannover Medical School.
Abstract
BACKGROUND: The symptoms of carbon monoxide (CO) poisoning are nonspecific, ranging from dizziness and headache to unconsciousness and death. A German national guideline on the diagnosis and treatment of this condition is lacking at present. METHODS: This review is based on a selective literature search in the PubMed and Cochrane databases, as well as on existing guidelines from abroad and expert recommendations on diagnosis and treatment. RESULTS: The initiation of 100% oxygen breathing as early as possible is the most important treatment for carbon monoxide poisoning. In case of CO poisoning, the reduced oxygen-carrying capacity of the blood, impairment of the cellular respiratory chain, and immune-modulating processes can lead to tissue injury in the myocardium and brain even after lowering of the carboxyhemoglobin (COHb) concentration. In patients with severe carbon monoxide poisoning, an ECG should be obtained and biomarkers for cardiac ischemia should be measured. Hyperbaric oxygen therapy (HBOT) should be critically considered and initiated within six hours in patients with neurologic deficits, unconsciousness, cardiac ischemia, pregnancy, and/or a very high COHb concentration. At present, there is no general recommendation for HBOT, in view of the heterogeneous state of the evidence from multiple trials. Therapeutic decision-making is directed toward the avoidance of sequelae such as cognitive dysfunction and cardiac complications, and the reduction of mortality. Smoke intoxication must be considered in the differential diagnosis. The state of the evidence on the diagnosis and treatment of this condition is not entirely clear. Alternative or supplementary pharmacological treatments now exist only on an experimental basis. CONCLUSION: High-quality, prospective, randomized trials that would enable a definitive judgment of the efficacy of HBOT are currently lacking.
BACKGROUND: The symptoms of carbon monoxide (CO) poisoning are nonspecific, ranging from dizziness and headache to unconsciousness and death. A German national guideline on the diagnosis and treatment of this condition is lacking at present. METHODS: This review is based on a selective literature search in the PubMed and Cochrane databases, as well as on existing guidelines from abroad and expert recommendations on diagnosis and treatment. RESULTS: The initiation of 100% oxygen breathing as early as possible is the most important treatment for carbon monoxidepoisoning. In case of CO poisoning, the reduced oxygen-carrying capacity of the blood, impairment of the cellular respiratory chain, and immune-modulating processes can lead to tissue injury in the myocardium and brain even after lowering of the carboxyhemoglobin (COHb) concentration. In patients with severe carbon monoxidepoisoning, an ECG should be obtained and biomarkers for cardiac ischemia should be measured. Hyperbaric oxygen therapy (HBOT) should be critically considered and initiated within six hours in patients with neurologic deficits, unconsciousness, cardiac ischemia, pregnancy, and/or a very high COHb concentration. At present, there is no general recommendation for HBOT, in view of the heterogeneous state of the evidence from multiple trials. Therapeutic decision-making is directed toward the avoidance of sequelae such as cognitive dysfunction and cardiac complications, and the reduction of mortality. Smoke intoxication must be considered in the differential diagnosis. The state of the evidence on the diagnosis and treatment of this condition is not entirely clear. Alternative or supplementary pharmacological treatments now exist only on an experimental basis. CONCLUSION: High-quality, prospective, randomized trials that would enable a definitive judgment of the efficacy of HBOT are currently lacking.
Authors: R B Parkinson; R O Hopkins; H B Cleavinger; L K Weaver; J Victoroff; J F Foley; E D Bigler Journal: Neurology Date: 2002-05-28 Impact factor: 9.910
Authors: Lindell K Weaver; Ramona O Hopkins; Karen J Chan; Susan Churchill; C Gregory Elliott; Terry P Clemmer; James F Orme; Frank O Thomas; Alan H Morris Journal: N Engl J Med Date: 2002-10-03 Impact factor: 91.245
Authors: Abdullah Al-Matrouk; Ali Al-Hemoud; Mohammed Al-Hasan; Yaqoub Alabouh; Amal Dashti; Haider Bojbarah Journal: Int J Environ Res Public Health Date: 2021-08-22 Impact factor: 3.390
Authors: Andrea Köhler; Felicitas M Zoll; Thomas Ploner; Alexander Hammer; Michael Joannidis; Herbert Tilg; Armin Finkenstedt; Frank Hartig Journal: Front Physiol Date: 2022-04-26 Impact factor: 4.755
Authors: Björn Jüttner; Hans-Jörg Busch; Andreas Callies; Harald Dormann; Thorsten Janisch; Guido Kaiser; Hella Körner-Göbel; Karsten Kluba; Stefan Kluge; Bernd A Leidel; Oliver Müller; Johannes Naser; Carsten Pohl; Karl Reiter; Dietmar Schneider; Enrico Staps; Wilhelm Welslau; Holger Wißuwa; Gabriele Wöbker; Cathleen Muche-Borowski Journal: Ger Med Sci Date: 2021-11-04